Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Why weight loss cannot be an aesthetic goal
How has the launch of GLP-1 medication disrupted weight loss/obesity care models globally? For a long time, obesity care was essentially a willpower conversation dressed in clinical language. Eat less, […] The post Why weight loss cannot be an aesthetic goal appeared first on Express Pharma.
Read Full Article
Express Pharma
OneSource Specialty Pharma and Formycon AG announce strategic manufacturing partnership for biosimilars
OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formycon AG (FSE: FYB, Prime Standard, “Formycon”), an independent biosimilar developer headquartered in Munich, announced a strategic manufacturing partnership for biosimilars. […] The post OneSource Specialty Pharma and Formycon AG announce strategic manufacturing partnership for biosimilars appeared first on Express Pharma.
Read Full Article
Pharma Tech
AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug
In licensing Zegfrovy, AstraZeneca has gained an already approved asset, with a label expansion potentially on the horizon.
Read Full Article
Pharma Tech
Novartis and Chai Discovery collaborate on antibody identification
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.
Read Full Article
Express Pharma
What India and Africa can teach each other on animal health – A rare IMEA-wide view on disease surveillance, biosecurity and vaccine access across borders
Animal health has become one of the defining priorities for agriculture across India, the Middle East and Africa (IMEA). Livestock, poultry and aquaculture support millions of farmers, strengthen rural economies […] The post What India and Africa can teach each other on animal health – A rare IMEA-wide view on disease surveillance, biosecurity and vaccine access across borders appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Express Pharma
Jul 14, 2026, 2:34 PM
Why weight loss cannot be an aesthetic goal
How has the launch of GLP-1 medication disrupted weight loss/obesity care models globally? For a long time, obesity care was essentially a willpower conversation dressed in clinical language. Eat less, […] The post Why weight loss cannot be an aesthetic goal appeared first on Express Pharma.
Express Pharma
Jul 14, 2026, 2:28 PM
OneSource Specialty Pharma and Formycon AG announce strategic manufacturing partnership for biosimilars
OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formycon AG (FSE: FYB, Prime Standard, “Formycon”), an independent biosimilar developer headquartered in Munich, announced a strategic manufacturing partnership for biosimilars. […] The post OneSource Specialty Pharma and Formycon AG announce strategic manufacturing partnership for biosimilars appeared first on Express Pharma.
Pharma Tech
Jul 14, 2026, 2:14 PM
AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug
In licensing Zegfrovy, AstraZeneca has gained an already approved asset, with a label expansion potentially on the horizon.
PharmaShots
Jul 14, 2026, 1:30 PM
The US FDA New Drug Approvals in June 2026
Shots: Company: Bayer Product: Ambelvist Active Ingredient: Gadoquatrane Disease: Enhance MRI Detection of Lesions Date: Jun 12, 2026 Shots: Company: GSK & Spero Therapeutics Product: Utebzi Active Ingredient: Tebipenem Pivoxil Disease: Complicated Urinary Tract Infections Date: Jun 17, 2026 Shots: Company: Viridian Therapeutics Product: Lumvoa Active Ingredient: Veligrotug-vvze Disease: Thyroid Eye Disease Date: Jun 26, 2026 Shots: The post The US FDA New Drug Approvals in June 2026 appeared first on PharmaShots.
PharmaShots
Jul 14, 2026, 12:30 PM
Innovent Biologics Licenses SP001 (IBI355) to Spero Therapeutics in a ~$1.1B Deal
Shots: Ref: Globenewswire | Image: Innovent & Spero | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Innovent Biologics Licenses SP001 (IBI355) to Spero Therapeutics in a ~$1.1B Deal appeared first on PharmaShots.
PharmaShots
Jul 14, 2026, 11:30 AM
BioMarin Reports the US FDA’s sNDA Acceptance for Full Approval of Voxzogo in Achondroplasia
Shots: Ref: PRnewswire | Image: BioMarin | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BioMarin Reports the US FDA’s sNDA Acceptance for Full Approval of Voxzogo in Achondroplasia appeared first on PharmaShots.
News
Latest industry coverage
Google News
Jul 14, 2026, 7:09 PM
The Race to Commercialize the World’s Most Powerful Psychedelic - WSJ
The Race to Commercialize the World’s Most Powerful Psychedelic WSJ
Google News
Jul 14, 2026, 6:21 PM
Business Watch: AkzoNobel gets another takeover offer; ARPA-H launches rare disease program - Chemical & Engineering News
Business Watch: AkzoNobel gets another takeover offer; ARPA-H launches rare disease program Chemical & Engineering News
Google News
Jul 14, 2026, 6:18 PM
The EU Commission's new draft merger guidelines - key takeaways for pharma companies - Herbert Smith Freehills Kramer
The EU Commission's new draft merger guidelines - key takeaways for pharma companies Herbert Smith Freehills Kramer
Google News
Jul 14, 2026, 6:04 PM
Penny for Your Thoughts: Episode 14 - Pharmaceutical Commerce
Penny for Your Thoughts: Episode 14 Pharmaceutical Commerce
Google News
Jul 14, 2026, 5:35 PM
Pennsylvania state budget to pump $125M into life sciences industry starved for capital - The Business Journals
Pennsylvania state budget to pump $125M into life sciences industry starved for capital The Business Journals
Google News
Jul 14, 2026, 5:31 PM
Pharma pricing policy threatens innovation - The Daily Star
Pharma pricing policy threatens innovation The Daily Star
Google News
Jul 14, 2026, 5:26 PM
Why Integration, Not AI, May Be the Most Important Factor in Pharma’s ERP Journey - ERP Today
Why Integration, Not AI, May Be the Most Important Factor in Pharma’s ERP Journey ERP Today
Google News
Jul 14, 2026, 5:17 PM
Pharma companies paid providers $14.7 billion in 2025. What does that mean? - Healthcare Brew
Pharma companies paid providers $14.7 billion in 2025. What does that mean? Healthcare Brew
Google News
Jul 14, 2026, 5:05 PM
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO - BioSpace
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO BioSpace
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer